A221805 Duloxetine to Prevent Oxaliplatin-induced Chemotherapy-induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study

NCT04137107

Duloxetine to Prevent Oxaliplatin-induced Chemotherapy-induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study

Associated Conditions

Colorectal Cancer

Principal Investigator

Sponsor

Alliance for Clinical Trials in Oncology

This study is being because we want to find out if duloxetine can prevent oxaliplatin-induced peripheral neuropathy (also called OIPN).